ProQR Therapeutics NV Analyst Event Transcript
Good day, and thank you for standing by. Welcome to the ProQR Analyst Event Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today.
I would now like to hand the conference over to your first speaker today, Sarah Kiely. Please go ahead.
Thank you, operator, and good day, everyone. I am Sarah Kiely, Vice President of Investor Relations and Corporate Communications at ProQR. We are very pleased to share with you today an overview of our clinical stage pipeline of RNA therapy for genetic eye diseases as well as to highlight our RNA editing technology platform.
Briefly, some logistics. This webcast can be accessed under the Events section of our website at www.proqr.com and will be available for replay later today. The slides for the webcast can be downloaded from the webcast player or directly from our website. I would like to bring your attention to the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |